Celora™ Vita is different because it delivers the most complete amino acid blend in its class, combining nine carefully selected amino acids to support full extracellular matrix renewal with full BCAA coverage, leucine, isoleucine and valine, for optimal tissue repair support.

Celora™ Vita is a suitable treatment for changes in overall skin quality and condition, rather than significant facial volume loss. It can help improve the appearance of dull or tired-looking skin, dehydration, fine lines, reduced firmness or elasticity, rough or uneven texture, crepey-looking skin, early signs of skin ageing, reduced skin resilience and loss of natural radiance.

Yes. Celora™ Vita is a CE–marked medical treatment and has been well tolerated across clinical evaluations, with no serious adverse events or treatment–related complications reported.

Skin quality depends on active fibroblasts maintaining collagen, elastin and hyaluronic acid within the extracellular matrix. With age and under biological stress, this process slows as fibroblast efficiency declines. Amino acids are essential substrates for structural skin proteins. As collagen and elastin production decreases from early adulthood, reduced amino acid availability limits protein synthesis. This contributes to loss of elasticity, hydration and dermal support. Celora™ Vita is designed to replenish the essential building blocks required for the efficient production of extracellular matrix proteins, supporting tissue quality and function.

Treatment involves a series of small, superficial injections across the treatment area. A topical numbing cream may be applied beforehand if required, although many patients find the treatment tolerable.

Downtime is generally minimal, but Celora™ Vita is still an injectable treatment. Therefore, immediately after treatment you may experience mild redness, slight swelling, small raised bumps at the injection points and occasional bruising. Most patients return to their usual daily activities straight after treatment.
Aftercare is similar to other injectable treatments and includes avoiding touching or massaging the treated area, avoiding make up, alcohol, strenuous exercise and saunas for the first 24 hours.

Typically a course of 3 treatments, spaced approximately 3 weeks apart. The frequency of maintenance treatments depends on your skin and how it responds, but can be approximately 4-6 months.

Celora™ Vita may not be appropriate during pregnancy or breastfeeding, if you have an active infection or inflammation in the treatment area, or because of certain allergies, medical conditions or medications. A full consultation is carried out to assess suitability for treatment.